1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Philippines Pharmaceuticals and Healthcare Report Q4 2016

Philippines Pharmaceuticals and Healthcare Report Q4 2016

  • October 2016
  • -
  • Business Monitor International
  • -
  • 99 pages

Includes 3 FREE quarterly updates

BMI View:

There will be broad healthcare policy continuity in the Philippines under President Rodrigo Duterte. In contrast to his other more controversial positions, Duterte's statements on healthcare are relatively more nuanced and in line with current policy directions. The appointment of Jean Paulyn Rusell- Ubial, an experienced official from the Department of Health, as health secretary will serve to further maintain the status quo. Risks to multinational drugmakers from Duterte's presidency lie instead in his management of the economy, as out-of-pocket payments are a dominant source of healthcare financing in the Philippines.

Headline Expenditure Projections


- Pharmaceuticals: PHP150.44bn (USD3.33bn) in 2015, rising to PHP156.19bn (USD3.26bn) in 2016; +3.8% in local currency terms and -2.1% in US dollar terms. Forecast in line with last quarter.

- Healthcare: PHP656.11bn (USD14.52bn) in 2015, rising to PHP722.32bn (USD15.06bn) in 2016; +10.1% in local currency terms and +3.8% in US dollar terms. Forecast in line with last quarter.

Table Of Contents

Philippines Pharmaceuticals and Healthcare Report Q4 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Philippines 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Philippines 2012-2020) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Philippines 2012-2020) 18
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Philippines 2012-2020) 18
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Philippines 2012-2020) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Philippines 2012-2020) 21
Patented Drug Market Forecast 22
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Philippines 2012-2020) 24
Generic Drug Market Forecast 25
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Philippines 2012-2020) 28
Over The Counter Forecast 29
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Philippines 2012-2020) 31
Pharmaceutical Trade Forecast 32
Table: Pharmaceutical Trade Data And Forecasts (Philippines 2014-2020) 35
Table: Pharmaceutical Trade Data And Forecasts local currency (Philippines 2014-2020) 35
Industry Risk/Reward Index 36
Asia Pacific Risk/Reward Index - Q4 2016 36
Philippines Risk/Reward Index 43
Rewards 43
Risks 44
Regulatory Review 45
Intellectual Property Issues 49
Pricing Regime 52
Reimbursement Regime 56
Market Overview 57
Healthcare Sector 58
Table: Healthcare Resources (Philippines 2010-2015) 61
Table: Healthcare Personnel (Philippines 2010-2015) 61
Table: Healthcare Activity (Philippines 2010-2015) 62
Health Insurance 62
Clinical Trials 68
Epidemiology 69
Competitive Landscape 71
Research-Based Industry 71
Table: Multinational Market Activity 71
Generic Drugmakers 72
Pharmaceutical Distribution 74
Pharmaceutical Retail Sector 76
Table: Overview Of BnB, BNB and P100 Programme 79
Table: Cost Of Generic Drugs In Philippines (PHP) 79
Table: Number Of BnBs And BNBs In Selected Philippine Regions 80
Company Profile 81
GlaxoSmithKline Philippines 81
Novartis 84
Demographic Forecast 88
Table: Population Headline Indicators (Philippines 1990-2025) 89
Table: Key Population Ratios (Philippines 1990-2025) 89
Table: Urban/Rural Population and Life Expectancy (Philippines 1990-2025) 90
Table: Population By Age Group (Philippines 1990-2025) 90
Table: Population By Age Group % (Philippines 1990-2025) 91
Glossary 93
Methodology 95
Pharmaceutical Expenditure Forecast Model 95
Healthcare Expenditure Forecast Model 95
Notes On Methodology 96
Risk/Reward Index Methodology 97
Index Overview 98
Table: Pharmaceutical Risk/Reward Index Indicators 98
Indicator Weightings 99

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.